August Guangzhou biotechnology conference highlights professional global bio similar drugs ushering in "golden age"

[Pharmaceutical Website exhibition report] in 2019, a large number of biological original research drugs encountered a cliff, and the global biological similar drugs ushered in a "golden age" of development Although biological similar drugs started late in China, with the increasingly standardized regulatory environment of biological similar drugs at home and abroad and the continuous improvement of relevant domestic guidelines, biological similar drugs as innovative generic drugs have been developed rapidly The domestic bioequivalent Fuhong hanlinlituximab was approved by nmpa, the new track of domestic bioequivalent drugs was opened, and the localization process was greatly accelerated At present, the mAb bio similar drugs of Sansheng pharmaceutical, baiaotai, Qilu pharmaceutical and other enterprises have been in the stage of application for listing, and many popular target bio similar drugs of Xinda biology, Xikang biology, Jiahe biology and other enterprises have also entered the clinical practice Guangzhou International Biotechnology Expo 2019 (BTE) will be held in Zone C, China Import and export commodities exhibition hall, Guangzhou from August 30 to September 1, 2019! The exhibition is jointly sponsored by China Association for the promotion of international science and technology, China protein drug quality alliance, Guangdong laboratory design and Construction Technology Association, Guangdong Biological Industry Association, Shenzhen biological medicine Promotion Association, Guangzhou Instrument Industry Association, gene industry, University, research capital alliance and Zhenwei Exhibition Co., Ltd   At the same time, we got Guangzhou International bio Island, Guangdong Pharmaceutical Association, Guangdong microbial society, Guangzhou Pharmaceutical Industry Association, Guangzhou biomedical public service platform, biomedical College of Guangdong University of technology, Shenzhen life science and Biotechnology Association, Shenzhen International Bio Valley Life Science Industrial Park, Zhuhai Pharmaceutical Association, Zhuhai Pharmaceutical Industry Association, Zhuhai City Food Safety Association, Zhongshan Pharmaceutical Association, Zhongshan Health Science and technology industrial base and many other industry associations, institutions and enterprises support and co host, which is an influential biotechnology conference in China China Association for the promotion of international science and technology is a national first-class association approved by the leading group of science and technology of the State Council of the people's Republic of China, registered with the Ministry of civil affairs, and the administrative unit of Party construction is the working committee of state organs The science and Technology Promotion Association has a group of expert resources including domestic and foreign scientists, educators, financiers, entrepreneurs, industrialists, management experts and engineering technicians Through organizing international meetings of domestic and foreign experts, it strengthens the development of international science and technology exchanges and economic cooperation, promotes the combination of science and technology and economy, promotes the industrialization of science and technology, industrial science and technology, and revitalizes China The China protein drug quality alliance has been strongly supported by the State Food and drug administration, the Ministry of science and technology, Tianjin and Binhai New Area of Tianjin It is a non-profit, product quality self-discipline and industrial technology innovation professional group Its members include Lizhu mAb, Yian Jishi, Sansheng Guojian, Jiahe biology, Fuhong Hanlin, Haizheng pharmaceutical, etc The alliance has successfully held conferences on the quality analysis of antibody drugs, serum-free cell culture, protein drug separation and purification and quality control technology and other fields of biopharmaceutical technology and practical training Industry leaders gather to discuss the frontier of biopharmaceutical In order to further explore the current situation of the development of bio similar drugs, and further understand the development environment and prospects of bio pharmaceutical industry, China Association for the promotion of international science and technology, in conjunction with Zhenwei Exhibition Co., Ltd., held "2019 China (Guangzhou) bio similar drug innovation and Development Forum" at the same time of the exhibition, invited a number of industry experts to give keynote speeches, and jointly discussed the new policies, regulations and policies of bio similar drug industry Downstream technology, preparation technology, clinical research, investment and financing and other hot and difficult topics concerned by enterprises, build a platform for exchange and cooperation in administration, production, learning, research, use and financing, promote technological innovation and industrial coordinated development, and realize the development of biopharmaceutical industry in the direction of industrialization, marketization and standardization   Antibody drugs and cellular immunotherapy are also the focus of experts, scholars and enterprise workers in the biopharmaceutical industry At the same time of the exhibition, China protein drug quality alliance will hold "antibody drugs and new drug R & D summit" and "cellular immunotherapy summit", focusing on "China's biopharmaceutical industry development status and opportunities", "gene editing humanization" The topics such as mouse technology and antibody diversity solutions, detection methods and quality control standards of monoclonal antibody biological products, and immunogenicity evaluation strategies and challenges of biological innovative drugs were discussed.